9 December 2024 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice on four medicines.

Zanubrutinib (Brukinsa) was accepted for the treatment of adult patients with marginal zone lymphoma who have already received a previous treatment. Marginal zone lymphoma is a rare type of cancer of the white blood cells.

Read SMC press release